Chargement en cours...
Clinical development of two innovative pharmaceutical forms of leuprorelin acetate
OBJECTIVES: Two innovative pharmaceutical forms of leuprorelin acetate have been developed as 1-month and 3-month implants for the treatment of advanced hormone-dependent prostate cancer. These products contain active substance dispersed homogeneously in a biodegradable polymer. Here we present the...
Enregistré dans:
| Auteurs principaux: | , , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
SAGE Publications
2013
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3547534/ https://ncbi.nlm.nih.gov/pubmed/23372606 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1756287212471096 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|